Serna Bio Announces Scientific Advisory Board [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
LONDON Jan. 10, 2025 /PRNewswire/ -- Serna Bio , an AI drug discovery company pioneering RNA-targeting small molecules, today announced the members of its Scientific Advisory Board (SAB). Established in 2021, Serna Bio is a preclinical drug discovery company with lead programs in neuro metabolism and obesity. The company is backed by leading investors including but not limited to, Y-combinator, Hummingbird Ventures, and 50Years. Serna Bio Logo (PRNewsfoto/Serna Bio) "We have established a truly differentiated platform to discover a novel class of small molecules - translational enhancers - and are using this to advance the development of therapies for diseases with no existing treatments , with a focus on genetically validated targets
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent CourtPR Newswire
- BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA [Yahoo! Finance]Yahoo! Finance
- BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CAPR Newswire
- Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Press Registration Is Now Open for the 2025 ACMG Annual Clinical Genetics Meeting [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 10/29/24 - Beat
BMRN
Sec Filings
- 12/3/24 - Form 4
- 11/14/24 - Form 4
- 11/12/24 - Form 144
- BMRN's page on the SEC website